Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

STERIS plc (NYSE:STE)

84.98
Delayed Data
As of Aug 21
 -0.15 / -0.18%
Today’s Change
63.80
Today|||52-Week Range
87.49
+26.10%
Year-to-Date
STE Regular Dividend: STE will begin trading ex-dividend on 08/25/17 with a $0.31 dividend payable to shareholders of record as of 08/29/17.
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
Aug 21 / Zacks.com - Paid Partner Content
Civitas Solutions (CIVI) Q3 Earnings Beat, Revenues Miss
Aug 15 / Zacks.com - Paid Partner Content
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
Aug 17 / Zacks.com - Paid Partner Content
STERIS (STE) Banks on Organic Growth, Competition Intense
Aug 14 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Align Technology (ALGN) Now
Aug 16 / Zacks.com - Paid Partner Content
Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes
Aug 14 / Zacks.com - Paid Partner Content
Haemonetics Plasma Arm Grows Strong, Blood Center Sluggish
Aug 16 / Zacks.com - Paid Partner Content
BioScrip (BIOS) Gains on CORE Initiatives, Competition Rife
Aug 11 / Zacks.com - Paid Partner Content
Varian (VAR) Rides on Oncology and Proton Therapy Businesses
Aug 16 / Zacks.com - Paid Partner Content
OPKO Health (OPK) Posts Narrower-than-Estimated Loss in Q2
Aug 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close85.13
Today’s open85.09
Day’s range84.73 - 85.27
Volume271,038
Average volume (3 months)505,339
Market cap$7.3B
Dividend yield1.46%
Data as of 4:02pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-17.95%
Earnings growth (this year)+7.91%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+16.71%
P/E ratio37.9
Price/Sales2.29
Price/Book2.58

Competitors

 Today’s
change
Today’s
% change
HRCHill-Rom Holdings In...+0.98+1.34%
WMGIWright Medical Group...-0.44-1.53%
MSAMSA Safety Inc+0.43+0.63%
ITGRInteger Holdings Cor...-0.40-0.90%
Data as of 4:02pm ET, 08/21/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.95
Annual revenue (last year)$2.6B
Annual profit (last year)$110.0M
Net profit margin4.21%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Walter M. Rosebrough
Chief Financial Officer, Treasurer &
Senior VP
Michael Joseph Tokich
Corporate headquarters
Leicester, Leicestershire

Forecasts